1Prince, M, Wimo, A, Guerchet, M, Ali, CG, Wu, YT, Prina, M. World Alzheimer Report. Alzheimer Disease International, 2015.
2Prince, M, Ali, GC, Guerchet, M, Prina, AM, Albanese, E, Wu, YT. Recent global trends in the prevalence and incidence of dementia, and survival with dementia. Alzheimers Res Ther 2016; 8: 23.
3Wu, YT, Beiser, AS, Breteler, MMB, Fratiglioni, L, Helmer, C, Hendrie, CH, et al. The changing prevalence and incidence of dementia over time – current evidence. Nat Rev Neurol 2017; 13: 327–39.
4Wu, YT, Fratiglioni, L, Matthews, FE, Lobo, A, Breteler, MMB, Skoog, I, et al. Dementia in Western Europe: epidemiological evidence and implications for policy making. Lancet Neurol 2016; 15: 116–24.
5Seshadri, S, Wolf, PA. Lifetime risk of stroke and dementia: current concepts, and estimates form the Framingham study. Lancet Neurol 2007; 6: 1106–14.
6Querfurth, HW, LaFerla, FM. Alzheimer disease. N Eng J Med 2010; 362: 329–44.
7Lopes Da Silva, S, Vellas, B, Elemans, S, Luchsinger, J, Kamphuis, P, Yaffe, K, et al. Plasma nutrient status of patients with Alzheimer's disease: systematic review and meta-analysis. Alzheimers Dement 2014; 10: 485–502.
8Holick, MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266–81.
9Haidich, AB. Meta-analysis in medical research. Hippokratia 2010; 14(suppl 1): 29–37.
10Hunter, JE, Schmidt, FL. Methods of Meta-analysis: Correcting Errors and Bias in Research Findings. Sage, 2006.
11Annweiler, C, Allali, G, Allain, P, Bridenbaugh, S, Schott, AM, Kressig, RW, et al. Vitamin D and cognitive performance in adults: a systematic review. Eur J Neurol 2009; 16: 1083–9.
12Balion, C, Griffith, LE, Strifler, L, Henderson, M, Patterson, C, Heckman, G, et al. Vitamin D, cognition, and dementia; A systematic review and meta-analysis. Neurology 2012; 79: 1397–405.
13Etgen, T, Sander, D, Bickel, H, Sander, K, Forstl, H. Vitamin D deficiency, cognitive impairment and dementia: a systematic review and meta-analysis. Dement Geriatr Cogn Disord 2012; 33: 297–305.
14Annweiler, C, Llewellyn, DJ, Beauchet, O. Low serum vitamin D concentrations in Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis 2013; 33: 659–74.
15Annweiler, C, Montero-Odasso, M, Llewellyn, DJ, Richard-Devantoy, S, Duque, G, Beauchet, O. Meta-analysis of memory and executive dysfunctions in relation to vitamin D. J Alzheimers Dis 2013; 37: 147–71.
16van der Schaft, J, Koek, HL, Dijkstra, E, Verhaar, HJJ, van der Schouw, YT, Emmelot-Vonk, MH. The association between vitamin D and cognition: a systematic review. Ageing Res Rev 2013; 12: 1013–23.
17Zhao, Y, Sun, Y, Ji, HF, Shen, L. Vitamin D levels in Alzheimer's and Parkinson's diseases: a meta-analysis. Nutrition 2013; 29: 828–32.
18Shen, L, Ji, HF. Vitamin D deficiency is associated with increased risk of Alzheimer's disease and dementia: evidence from meta-analysis. Nutr J 2015; 14: 76.
19Cao, L, Tan, L, Wang, HF, Jiang, T, Zhu, XC, Lu, H, et al. Dietary patterns and risk of dementia: a systematic review and meta-analysis of cohort studies. Mol Neurobiol 2016; 53: 6144–54.
20Sommer, I, Griebler, U, Kien, C, Auer, S, Klerings, I, Hammer, R, et al. Vitamin D deficiency as a risk factor for dementia: a systematic review and meta-analysis. BMC Geriatr 2017; 17: 16.
21Becker, LA, Oxman, AD. Overview of reviews. In Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] (eds Higgins, JPT, Green, S). The Cochrane Collaboration, 2011, pp.1–21.
22Moher, D, Liberati, A, Tetzlaff, J, Altman, DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: 2535.
23Shea, BJ, Girmshaw, JM, Wells, GA, Boers, M, Andersson, N, Hamel, C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systemic reviews. BMC Med Res Methodol 2007; 7: 10.
24Shea, BJ, Hamel, C, Wells, GA, Bouter, LM, Kristjansson, E, Grimshaw, J, et al. AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systemic reviews. J Clin Epidemiol 2009; 62: 1013–20.
25Shea, BJ, Bouter, LM, Peterson, J, Boers, M, Andersson, N, Ortiz, Z, et al. External validation of a measurement tool to assess systematic reviews (AMSTAR). PLoS ONE 2007; 2: e1350.
26Montori, VM, Wilczynski, NL, Morgan, D, Haynes, RB. Optimal search strategy for retrieving systematic reviews from Medline: analytical survey. BMJ 2004; 330: 68.
27Onasanya, O, Lyer, G, Lucas, E, Lin, D, Singh, S, Alexander, GC. Association between exogenous testosterone and cardiovascular events: an overview of systematic reviews. Lancet Diabetes Endocrinol 2016; 4: 943–56.
28Barnard, K, Colon-Emeric, C. Extraskeletal effects of vitamin D in older adults: cardiovascular disease, mortality, mood, and cognition. Am J Geriatr Pharmacother 2010; 8: 4–33.
29Iolascon, G, Gimigliano, R, Bianco, M, de Sire, A, Moretti, A, Giusti, A, et al. Are dietary supplements and nutraceuticals effective for musculoskeletal health and cognitive function? A scoping review. J Nutri Health Aging 2017; 21: 527–38.
30Killin, LO, Starr, JM, Shiue, IJ, Russ, TC. Environmental risk factors for dementia: a systematic review. BMC Geriatr 2016; 16: 175.
31Lehert, P, Villaseca, P, Hogervorst, E, Maki, PM, Henderson, VW. Individually modifiable risk factors to ameliorate cognitive aging: a systematic review and meta-analysis. Climacteric 2015; 18: 678–89.
32Di Marco, LY, Marzo, A, Munoz-Ruiz, M, Ikram, MA, Kivipelto, M, Ruefenacht, D, et al. Modifiable lifestyle factors in dementia: a systematic review of longitudinal observational cohort studies. J Alzheimers Dis 2014; 42: 119–35.
33Chen, S, Brodaty, H, O'Leary, F. The relationship of nutrition to cognitive function in older adults: a systematic review of RCTs. Int Psychogeriatr 2015; 27: S120.
34GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004; 328: 1490.
35Wolf, FM. Meta-Analysis: Quantitative Methods for Research Synthesis. Sage, 1986.
36Stroup, DF, Berlin, JA, Morton, SC, Olkin, I, Williamson, GD, Rennie, D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008–12.
37Ionnidis, JP, Haidich, AB, Pappa, M, Pantazis, N, Kokori, SI, Tektonidou, MG, et al. Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 2001; 286: 821–30.
38Annweiler, C, Dursun, E, Féron, F, Gezen-Ak, D, Kalueff, AV, Littlejohns, T, et al. Vitamin D and cognition in older adults: updates international recommendations. J Intern Med 2015; 277: 45–57.
39Aghajafari, F, Nagulesapillai, T, Ronksley, PE, Tough, SC, O'Beirne, M, Rabi, D. Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies. BMJ 2013; 346: f1169.
40Singh, RJ. Are clinical laboratories prepared for accurate testing of 25-hydroxy vitamin D? Clin Chem 2008; 54: 221–3.
41Sempos, CT, Vesper, HW, Phinney, KW, Thienpont, LM, Coates, PM, Vitamin D Standardization Program (VDSP). Vitamin D status as an international issue: national surveys and the problem of standardization. Scand J Clin Lab Invest Suppl 2012; 243: 32–40.
42Bailey, D, Veljkovic, K, Yazdanpanah, M, Adeli, K. Analytical measurement and clinical relevance of vitamin D(3) C3-epimer. Clin Biochem 2013; 46: 190–6.
43Aghajafari, F, Field, CJ, Rabi, D, Kaplan, BJ, Maggiore, JA, O'Beirne, M, et al. Plasma 3-epi-25-hydroxycholecalciferol can alter the assessment of vitamin D status using the current reference ranges for pregnant women and their newborns. J Nutr 2016; 146: 70–5.
44Spiro, A, Buttriss, JL. Vitamin D: an overview of vitamin D status and intake in Europe. Nutr Bull 2014; 39: 322–50.
45Panwar, B, Judd, SE, Howard, VJ, Jenny, NS, Wadley, VG, Gutiérrez, OM. Vitamin D, fibroblast growth factor 23 and incident cognitive impairment: findings from the REGARDS study. PLoS ONE 2016; 11: e0165671.
46Van Schoor, NM, Comijs, HC, Llewellyn, DJ, Lips, P. Cross-sectional and longitudinal associations between serum 25-hydroxyvitamin D and cognitive functioning. Int Psychogeriatr 2016; 28: 759–68.
47Annweiler, C, Fantino, B, Gautier, J, Beaudenon, M, Thiery, S, Beauchet, O. Cognitive effects of vitamin D supplementation in older outpatients visiting a memory clinic: a pre-post study. J Am Geriatr Soc 2012; 60: 793–5.
48Stein, MS, Scherer, SC, Ladd, KS, Harriosn, LC. A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer's disease. J Alzheimers Dis 2011; 26: 477–84.
49Corless, D, Eillis, M, Dawson, E, Freaser, F. Using activities of daily living assessment to measure the effectiveness of vitamin D supplements in elderly long-stay patients. Br J Occup Ther 1987; 50: 60–2.